TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson's Disease

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Bender, Andreas ^a,b   Desplats, Paula ^b   Spencer, Brian ^b   Rockenstein, Edward ^b   Adame, Anthony ^b   Elstner, Matthias ^a   Laub, Christoph ^a   Mueller, Sarina ^a   Koob, Andrew O ^a   Mante, Michael ^b   Pham, Emily ^b   Klopstock, Thomas ^a   Masliah, Eliezer ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CARRIER PROTEIN; COMPLEX I PROTEIN; LENTIVIRUS VECTOR; MITOCHONDRIAL DNA; OXIDOREDUCTASE; TRANSLOCASE OF THE OUTER MITOCHONDRIAL MEMBRANE 40; UNCLASSIFIED DRUG; MITOCHONDRIAL OUTER MEMBRANE PROTEIN 35-KDA, MOUSE; MITOCHONDRIAL PROTEIN;

AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; ENERGY YIELD; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; RAT; ANIMAL; BRAIN; GENE DELETION; GENE EXPRESSION; GENETICS; METABOLISM; MITOCHONDRIAL GENOME; MITOCHONDRION; MUTATION; PATHOLOGY; TRANSGENIC MOUSE;

LENTIVIRUS; MUS MUSCULUS;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; DNA DAMAGE; FEMALE; GENE EXPRESSION; GENOME, MITOCHONDRIAL; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUTATION; OXIDATIVE STRESS; PARKINSON DISEASE; SEQUENCE DELETION;

EID: 84876561267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062277     Document Type: Article

References (54)

1. Schapira AH, (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7: 97-109.
2. Banerjee R, Starkov AA, Beal MF, Thomas B, (2009) Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim Biophys Acta 1792: 651-663.
3. Mann VM, Cooper JM, Daniel SE, Srai K, Jenner P, et al. (1994) Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 36: 876-881.
4. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, et al. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269.
5. Bindoff LA, Birch-Machin M, Cartlidge NE, Parker WD Jr, Turnbull DM, (1989) Mitochondrial function in Parkinson's disease. Lancet 2: 49.
6. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, et al. (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38: 515-517.
7. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, et al. (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38: 518-520.
8. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, et al. (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14: 467-475.
9. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
10. Hashimoto M, Masliah E, (1999) Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol 9: 707-720.
11. Trojanowski JQ, Lee VM, (2000) "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann N Y Acad Sci 924: 62-67.
12. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
13. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
14. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, et al. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265-1269.
15. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, et al. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26: 41-50.
16. Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E, (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186: 158-172.
17. Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P (2008) Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci.
18. Li WW, Yang R, Guo JC, Ren HM, Zha XL, et al. (2007) Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport 18: 1543-1546.
19. Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P, (2009) Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int J Biochem Cell Biol 41: 2015-2024.
20. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impairs complex I in human dopaminergic neuronal cultures and Parkinson's disease brain. J Biol Chem.
21. Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, et al. (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99: 14524-14529.
22. Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, et al. (2006) Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis 21: 541-548.
23. Reeve AK, Krishnan KJ, Elson JL, Morris CM, Bender A, et al. (2008) Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet 82: 228-235.
24. Krishnan KJ, Bender A, Taylor RW, Turnbull DM, (2007) A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells. Anal Biochem 370: 127-129.
25. He L, Chinnery PF, Durham SE, Blakely EL, Wardell TM, et al. (2002) Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res 30: e68.
26. Naldini L, Verma IM, (2000) Lentiviral vectors. Adv Virus Res 55: 599-609.
27. Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, et al. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 23: 1992-1996.
28. Mucke L, Abraham CR, Ruppe MD, Rockenstein EM, Toggas SM, et al. (1995) Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein. J Exp Med 181: 1551-1556.
29. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, et al. (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193.
30. McFarland MA, Ellis CE, Markey SP, Nussbaum RL, (2008) Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics 7: 2123-2137.
31. Yamamoto H, Itoh N, Kawano S, Yatsukawa Y, Momose T, et al. (2011) Dual role of the receptor Tom20 in specificity and efficiency of protein import into mitochondria. Proceedings of the National Academy of Sciences of the United States of America 108: 91-96.
32. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature genetics 18: 106-108.
33. Choubey V, Safiulina D, Vaarmann A, Cagalinec M, Wareski P, et al. (2011) Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. The Journal of biological chemistry 286: 10814-10824.
34. Beal MF, (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism & related disorders 15Suppl 3: S189-194.
35. Clayton DA, (1984) Transcription of the mammalian mitochondrial genome. Annual review of biochemistry 53: 573-594.
36. Totterdell S, Meredith GE, (2005) Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Neuroscience 135: 907-913.
37. Devi L, Anandatheerthavarada HK, (2010) Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases. Biochim Biophys Acta 1802: 11-19.
38. Zhang L, Zhang C, Zhu Y, Cai Q, Chan P, et al. (2008) Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C-terminal specific monoclonal antibody. Brain Res.
39. Meisinger C, Ryan MT, Hill K, Model K, Lim JH, et al. (2001) Protein import channel of the outer mitochondrial membrane: a highly stable Tom40-Tom22 core structure differentially interacts with preproteins, small tom proteins, and import receptors. Mol Cell Biol 21: 2337-2348.
40. Pennington K, Peng J, Hung CC, Banks RE, Robinson PA, (2010) Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells. J Proteome Res 9: 2390-2401.
41. Goncalves S, Outeiro TF (2013) Assessing the Subcellular Dynamics of Alpha-synuclein Using Photoactivation Microscopy. Molecular neurobiology.
42. Zigoneanu IG, Yang YJ, Krois AS, Haque E, Pielak GJ, (2012) Interaction of alpha-synuclein with vesicles that mimic mitochondrial membranes. Biochimica et biophysica acta 1818: 512-519.
43. Bender A, Schwarzkopf RM, McMillan A, Krishnan KJ, Rieder G, et al. (2008) Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol.
44. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, et al. (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102: 3413-3418.
45. Roses AD, (2010) An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. Archives of neurology 67: 536-541.
46. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, et al. (2009) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J.
47. Bruno D, Pomara N, Nierenberg J, Ritchie JC, Lutz MW, et al. (2012) Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants. Experimental gerontology 47: 347-352.
48. Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature reviews Neurology.
49. Chong MS, Goh LK, Lim WS, Chan M, Tay L, et al. (2013) Gene Expression Profiling of Peripheral Blood Leukocytes Shows Consistent Longitudinal Downregulation of TOMM40 and Upregulation of KIR2DL5A, PLOD1, and SLC2A8 Among Fast Progressors in Early Alzheimer's Disease. Journal of Alzheimer's disease: JAD 34: 399-405.
50. Manczak M, Calkins MJ, Reddy PH, (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Human molecular genetics 20: 2495-2509.
51. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK, (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. The Journal of neuroscience: the official journal of the Society for Neuroscience 26: 9057-9068.
52. Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, et al. (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Human molecular genetics 20: 1438-1455.
53. Scherz-Shouval R, Elazar Z, (2007) ROS, mitochondria and the regulation of autophagy. Trends in cell biology 17: 422-427.
54. Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, et al. (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. The Journal of neuroscience: the official journal of the Society for Neuroscience 29: 13578-13588.